Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: cyclophosphamide, methotrexate, fluorouracil, PEG-filgrastim
Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Amgen